Literature DB >> 856365

Polymyositis.

W G Bradley.   

Abstract

Polymyositis is a treatable and curable disease. Unfortunately, patients with polymyositis are still frequently diagnosed as having muscular dystrophy. It is important to have a high index of suspicion of polymyositis, and to recognize that the detailed symptoms and signs and the overall picture are different from the relatively clear-cut pattern of the muscular dystrophies. Treatment of polymyositis is rewarding, although it frequently requires considerable resilience from both patient and doctor to achieve the best results. A detailed search for an underlying aetiology should be made, and a carcinoma should be suspected in elderly patients and those with dermatomyositis. In patients in whom polymyositis is related to a carcinoma, the latter may be at a stage where total excision is possible.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856365

Source DB:  PubMed          Journal:  Br J Hosp Med        ISSN: 0007-1064


  2 in total

1.  Antibodies to nuclear antigens in polymyositis: relationship to autoimmune 'overlap syndromes' and carcinoma.

Authors:  P J Venables; P A Mumford; R N Maini
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

2.  Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial.

Authors:  Nobuyuki Miyasaka; Masako Hara; Takao Koike; Eizo Saito; Masahito Yamada; Yoshiya Tanaka
Journal:  Mod Rheumatol       Date:  2011-10-05       Impact factor: 3.023

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.